Search:
 
This image is of a spacer graphic
This is an image of the whats new header
  Username:

Password:


Forgot Password?

+ Join NHF or Renew Your Membership
+ Personalize this Web site
+ Subscribe to NHF eNotes, our Monthly Online Newsletter
+ Donate to NHF
+ Discussion Groups
+ Chapter Center
This image is of a spacer graphic
-About Us
 Fast Facts
 Hechos y Respuestas Rápidas
 Chief Executive Officer
 Board Members
 Meet Our Senior Staff
 Financial Statements
 Chapters
 Employment
 Scholarships
 Governance

 

 

 
 
 

Search Clinical Trials
Parent Therapeutic Areas: Hematology

Hemophilia

California

Duarte : City of Hope

An International, Randomized, Controlled Trial of Immune-Tolerance Induction

Duarte : City of Hope

Hemophilia Inhibitor Genetics Study

Duarte : City of Hope

Immune Tolerance Induction Study in Patients with Severe Type A Haemophilia with Inhibitor after Failure of a Previous Induction of Immune TOlerance with FVII Concentrates without Von Willebrand Factor Rescue

Michigan

Detroit : Henry Ford Health System - Josephine Ford Cancer Center

Pain in the bleeding disorders community

New York

New York : Mount Sinai Medical Center

Advate Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method (Advate rAHF PFM): A Phase 4 Study Comparing Two Prophylactic Regimens in Subjects with Severe or Moderately Severe Hemophilia A [060201]

New York : Mount Sinai Medical Center

Advate Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method (Advate rAHF PFM): A Phase 4 Study Comparing Two Prophylactic Regimens in Subjects with Severe or Moderately Severe Hemophilia A [060201]